Top Markets
Coin of the day
BioNexus Gene Lab Corp. BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp.

BGLC
株式のランク #35594
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala... BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
株価
$1.50
最終同期: 2026-09-21
時価総額
$3.63M
変化(1日)
-4.46%
変化(1年)
-72.68%
MY
取引 BioNexus Gene Lab Corp. (BGLC)

カテゴリー

BioNexus Gene Lab Corp.(BGLC)の利益
Jun 2026 時点の利益 TTM: $-2.58M
BioNexus Gene Lab Corp. の最新の財務報告によると、同社の現在の利益は $-2.58M です。2023 年には $-2.61M の利益を上げ、これは 2022 年の利益 $-303.66K と 減少 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
BioNexus Gene Lab Corp. の利益の推移(2016 〜 2026)
各年末の利益
利益 変化
2026 (TTM) $-2.58M 61.47%
2024 $-1.59M -38.84%
2023 $-2.61M 758.71%
2022 $-303.66K -129.12%
2021 $1.04M -17.40%
2020 $1.26M -557.92%
2019 $-275.71K -560.27%
2018 $59.90K -150.16%
2017 $-119.41K 14,201.08%
2016 $-835.00 0.00%
同業他社の利益
企業 利益 利益の差
$2.69B -104,366.42%
US
$1.78B -69,051.75%
US
- -
US
$934.20M -36,377.72%
US
- -
US